187 related articles for article (PubMed ID: 31272240)
1. β-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.
Hadipour Dehshal M; Tabrizi Namini M; Hantoushzadeh R; Yousefi Darestani S
Hemoglobin; 2019 May; 43(3):166-173. PubMed ID: 31272240
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.
Haghpanah S; Vahdati S; Karimi M
Hemoglobin; 2017 May; 41(3):169-174. PubMed ID: 28741988
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent β-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
Sarihi R; Amirizadeh N; Oodi A; Azarkeivan A
Hemoglobin; 2020 Jan; 44(1):31-36. PubMed ID: 32400249
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hemoglobinopathies and thalassemias in individuals referred to the haematology research centre, Shiraz University of Medical Sciences, Shiraz, Iran from 2006 to 2011.
Haghpanah S; Ramzi M; Zakerinia M; Nourani Khojasteh H; Haghshenas M; Rezaei N; Moayed V; Rezaei A; Karimi M
Hemoglobin; 2014; 38(4):287-8. PubMed ID: 24941048
[TBL] [Abstract][Full Text] [Related]
5. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.
Farashi S; Bayat N; Faramarzi Garous N; Ashki M; Montajabi Niat M; Vakili S; Imanian H; Zeinali S; Najmabadi H; Azarkeivan A
Hemoglobin; 2015; 39(3):201-6. PubMed ID: 26084319
[TBL] [Abstract][Full Text] [Related]
6. Thalassemias and hemoglobinopathies in Turkey.
Canatan D
Hemoglobin; 2014; 38(5):305-7. PubMed ID: 25030194
[TBL] [Abstract][Full Text] [Related]
7. The diminishing trend of β-thalassemia in Southern Iran from 1997 to 2011: the impact of preventive strategies.
Joulaei H; Shahbazi M; Nazemzadegan B; Rastgar M; Hadibarhaghtalab M; Heydari M; Ghaffarpasand F; Rahimi N
Hemoglobin; 2014; 38(1):19-23. PubMed ID: 24274135
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of thalassemia intermedia in Iran.
Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
[TBL] [Abstract][Full Text] [Related]
9. Thalassemia Status in Cambodia.
Sophâl C
Hemoglobin; 2022 Jan; 46(1):10-11. PubMed ID: 35950584
[TBL] [Abstract][Full Text] [Related]
10. Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.
Rahimi Z
Biomed Res Int; 2013; 2013():803487. PubMed ID: 23853772
[TBL] [Abstract][Full Text] [Related]
11. Changing patterns in the epidemiology of β-thalassemia.
Kattamis A; Forni GL; Aydinok Y; Viprakasit V
Eur J Haematol; 2020 Dec; 105(6):692-703. PubMed ID: 32886826
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the national prevention program in iran, 2007-2009: the accomplishments and challenges with reflections on the path ahead.
Hadipour Dehshal M; Tabrizi Namini M; Ahmadvand A; Manshadi M; Sadeghian Varnosfaderani F; Abolghasemi H
Hemoglobin; 2014; 38(3):179-87. PubMed ID: 24669933
[TBL] [Abstract][Full Text] [Related]
13. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele.
Karimi M; Yarmohammadi H; Farjadian S; Zeinali S; Moghaddam Z; Cappellini MD; Giordano PC
Hemoglobin; 2002 May; 26(2):147-54. PubMed ID: 12144057
[TBL] [Abstract][Full Text] [Related]
14. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
Rafsanjani KA; Mafi N; Tafreshi RI
Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Thalassemia Traits and Iron Deficiency Anemia in Sindh, Pakistan.
Kandhro AH; Prachayasittikul V; Isarankura Na-Ayudhya C; Nuchnoi P
Hemoglobin; 2017 May; 41(3):157-163. PubMed ID: 28745572
[TBL] [Abstract][Full Text] [Related]
16. Hematological phenotype of the IVS-I-5 (G > C) beta-thalassemia mutation and assessment of Iran's national screening criteria.
Eshghi P; Rashidi A; Zadeh-Vakili A; Miri-Moghadam E
Hemoglobin; 2008; 32(5):440-5. PubMed ID: 18932068
[TBL] [Abstract][Full Text] [Related]
17. Premarital hemoglobinopathy screening program results of a province in the Black Sea region of Turkey: three years' experience.
Ozdemır S; Oruc MA; Yazıcıoglu B; Turkan S
Postgrad Med; 2023 Nov; 135(8):818-823. PubMed ID: 38019185
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study.
Mirmomen S; Alavian SM; Hajarizadeh B; Kafaee J; Yektaparast B; Zahedi MJ; Zand V; Azami AA; Hosseini MM; Faridi AR; Davari K; Hajibeigi B
Arch Iran Med; 2006 Oct; 9(4):319-23. PubMed ID: 17061602
[TBL] [Abstract][Full Text] [Related]
19. The survival rate of patients with beta-thalassemia major and intermedia and its trends in recent years in Iran.
Ansari-Moghaddam A; Adineh HA; Zareban I; Mohammadi M; Maghsoodlu M
Epidemiol Health; 2018; 40():e2018048. PubMed ID: 30336663
[TBL] [Abstract][Full Text] [Related]
20. Point-of-Care Diagnostic Test for Beta-Thalassemia.
An R; Avanaki A; Thota P; Nemade S; Mehta A; Gurkan UA
Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
